Perfeziona la tua ricerca

  • Libri (11)

a

Fascia di prezzo personalizzata (EUR)

a

Professor jose biller (11 risultati)

Autore: 
Perfeziona con la Ricerca avanzata
  • Lingua: Inglese

    Editore: TFM Publishing Ltd, Harley, 2011

    1903378761 / 9781903378762

    • Rilegato

    Da: Grand Eagle Retail, Bensenville, IL, U.S.A.Grand Eagle Retail

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 62,69

     Spedizione gratuita 
    Spedito in U.S.A.

    Quantità: 1 disponibile

    Hardcover. Condizione: new. Hardcover. Winner of a HIGHLY COMMENDED AWARD in the Neurology category of the 2012 BMA Medical Book Competition.More than five million people die from stroke each year. Stroke is also the leading cause of adult disability, affecting over 20 million people worldwide, with two-thirds of stroke victims left permanently disabled. We now know that speed of intervention is critical and patient outcomes are determined by a very narrow therapeutic window, during which physicians need to be able to make their choice of treatment rapidly, based on the best evidence available.The purpose of this book is to review that evidence, for both medical and surgical therapies as well as preventative strategies, drawing on the expertise of leading international authorities to distinguish the issues for which there is a consensus on best practice from those for which the evidence remains inconclusive.For example, for patients with acute ischemic stroke the first choice is intravenous thrombolytic therapy, but does a treatment window of 0-3 hours deliver outcomes significantly better than one of 3-4.5 hours? Arterial hypertension is the single most important modifiable risk factor for ischemic stroke, but what are the effects of blood pressure reduction among acute stroke patients? How effective is blood pressure lowering in primary intracerebral hemorrhage? What are the arguments in favour of continuation versus temporary discontinuation of antihypertensive therapy immediately after acute ischemic stroke? Endovascular procedures (carotid angioplasty/stenting) are increasingly important but what do the data tell us about their safety? Or durability? How do they compare with carotid endarterectomy? The management of unruptured intracranial aneurysms is rife with controversies; clip, coil, wait and watch? The authors examine the evidence for and against.Other sections examine the impact of various risk factors, and special populations. A section on stroke after cardiovascular surgeries reviews the incidence and management of stroke following a whole range of procedures. Another examines special risks during pregnancy.Lastly, the book reviews our understanding of childhood stroke and presents current best practice recommendations for this most challenging group of patients. Over five million people die from stroke each year. We now know that speed of intervention is critical and patient outcomes are determined by a very narrow therapeutic window, during which physicians need to be able to make their choice of treatment rapidly, based on the best evidence available. This book intends to review that evidence. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

  • Lingua: Inglese

    Editore: TFM Publishing Ltd, GB, 2011

    1903378761 / 9781903378762

    • Rilegato

    Da: Rarewaves.com USA, London, LONDO, Regno UnitoRarewaves.com USA

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 64,20

     Spedizione gratuita 
    Spedito da Regno Unito a U.S.A.

    Quantità: 2 disponibili

    Hardback. Condizione: New. Over five million people die from stroke each year. Stroke is also the leading cause of adult disability, affecting over 20 million people world-wide, with two-thirds of stroke victims left permanently disabled. We now know that speed of intervention is critical and patient outcomes are determined by a very narrow therapeutic window, during which physicians need to be able to make their choice of treatment rapidly, based on the best evidence available. The purpose of this book is to review that evidence, for both medical and surgical therapies as well as preventative strategies, drawing on the expertise of leading international authorities to distinguish the issues for which there is a consensus on best practice from those for which the evidence remains inconclusive. For example, for patients with acute ischemic stroke the first choice is intravenous thrombolytic therapy, but does a treatment window of 0-3 hours deliver outcomes significantly better than one of 3-4.5 hours? Arterial hypertension is the single most important modifiable risk factor for ischemic stroke, but what are the effects of blood pressure reduction among acute stroke patients? How effective is blood pressure lowering in primary intracerebral hemorrhage? What are the arguments in favour of continuation versus temporary discontinuation of anti-hypertensive therapy immediately after acute ischemic stroke? Endovascular procedures (carotid angioplasty/stenting) are increasingly important but what do the data tell us about their safety? Or durability? How do they compare with carotid endarterectomy? The management of unruptured intracranial aneurysms is rife with controversies; clip, coil, wait and watch? The authors examine the evidence for and against. Other sections examine the impact of various risk factors, and special populations. A section on stroke after cardiovascular surgeries reviews the incidence and management of stroke following a whole range of procedures including coronary artery bypass grafting, valve replacement surgery, congenital heart disease treatment, aortic surgery, cardiac transplantation and post-carotid endarterectomy. Another examines special risks during pregnancy. Lastly, the book reviews our understanding of childhood stroke -- perinatal, infants and older children, adolescents and young adults - and presents current best practice recommendations for this most challenging group of patients.…

  • Lingua: Inglese

    Editore: TFM Publishing Limited, 2011

    1903378761 / 9781903378762

    • Rilegato

    Da: Majestic Books, Hounslow, Regno UnitoMajestic Books

    Venditore con 4 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 56,25

    EUR 7,81 spedizione 
    Spedito da Regno Unito a U.S.A.

    Quantità: 3 disponibili

    Condizione: New. pp. x + 334 Illus.

  • Lingua: Inglese

    Editore: TFM Publishing Limited, 2011

    1903378761 / 9781903378762

    • Rilegato

    Da: Books Puddle, Woodside, NY, U.S.A.Books Puddle

    Venditore con 4 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 82,54

    EUR 3,63 spedizione 
    Spedito in U.S.A.

    Quantità: 3 disponibili

    Condizione: New. pp. x + 334.

  • Lingua: Inglese

    Editore: TFM Publishing Limited, 2011

    1903378761 / 9781903378762

    • Rilegato

    Da: Biblios, frankfurt am main, HESSE, GermaniaBiblios

    Venditore con 4 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 74,78

    EUR 9,95 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 3 disponibili

    Condizione: New. pp. x + 334.

  • Lingua: Inglese

    Editore: TFM Publishing Ltd, GB, 2011

    1903378761 / 9781903378762

    • Rilegato

    Da: Rarewaves USA, HEBRON, KY, U.S.A.Rarewaves USA

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 89,74

     Spedizione gratuita 
    Spedito in U.S.A.

    Quantità: 11 disponibili

    Hardback. Condizione: New. Over five million people die from stroke each year. Stroke is also the leading cause of adult disability, affecting over 20 million people world-wide, with two-thirds of stroke victims left permanently disabled. We now know that speed of intervention is critical and patient outcomes are determined by a very narrow therapeutic window, during which physicians need to be able to make their choice of treatment rapidly, based on the best evidence available. The purpose of this book is to review that evidence, for both medical and surgical therapies as well as preventative strategies, drawing on the expertise of leading international authorities to distinguish the issues for which there is a consensus on best practice from those for which the evidence remains inconclusive. For example, for patients with acute ischemic stroke the first choice is intravenous thrombolytic therapy, but does a treatment window of 0-3 hours deliver outcomes significantly better than one of 3-4.5 hours? Arterial hypertension is the single most important modifiable risk factor for ischemic stroke, but what are the effects of blood pressure reduction among acute stroke patients? How effective is blood pressure lowering in primary intracerebral hemorrhage? What are the arguments in favour of continuation versus temporary discontinuation of anti-hypertensive therapy immediately after acute ischemic stroke? Endovascular procedures (carotid angioplasty/stenting) are increasingly important but what do the data tell us about their safety? Or durability? How do they compare with carotid endarterectomy? The management of unruptured intracranial aneurysms is rife with controversies; clip, coil, wait and watch? The authors examine the evidence for and against. Other sections examine the impact of various risk factors, and special populations. A section on stroke after cardiovascular surgeries reviews the incidence and management of stroke following a whole range of procedures including coronary artery bypass grafting, valve replacement surgery, congenital heart disease treatment, aortic surgery, cardiac transplantation and post-carotid endarterectomy. Another examines special risks during pregnancy. Lastly, the book reviews our understanding of childhood stroke -- perinatal, infants and older children, adolescents and young adults - and presents current best practice recommendations for this most challenging group of patients.…

  • Lingua: Inglese

    Editore: TFM Publishing Ltd (UK), 2011

    1903378761 / 9781903378762

    • Rilegato

    Da: Gazelle Books, Lancaster, LANCA, Regno UnitoGazelle Books

    Venditore con 4 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 46,40

    EUR 66,07 spedizione 
    Spedito da Regno Unito a U.S.A.

    Quantità: 4 disponibili

    Hardback. Condizione: New. New Book, Direct from Publisher.

  • Lingua: Inglese

    Editore: TFM Publishing Ltd, Harley, 2011

    1903378761 / 9781903378762

    • Rilegato

    Da: AussieBookSeller, Truganina, VIC, AustraliaAussieBookSeller

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 96,54

    EUR 33,66 spedizione 
    Spedito da Australia a U.S.A.

    Quantità: 1 disponibile

    Hardcover. Condizione: new. Hardcover. Winner of a HIGHLY COMMENDED AWARD in the Neurology category of the 2012 BMA Medical Book Competition.More than five million people die from stroke each year. Stroke is also the leading cause of adult disability, affecting over 20 million people worldwide, with two-thirds of stroke victims left permanently disabled. We now know that speed of intervention is critical and patient outcomes are determined by a very narrow therapeutic window, during which physicians need to be able to make their choice of treatment rapidly, based on the best evidence available.The purpose of this book is to review that evidence, for both medical and surgical therapies as well as preventative strategies, drawing on the expertise of leading international authorities to distinguish the issues for which there is a consensus on best practice from those for which the evidence remains inconclusive.For example, for patients with acute ischemic stroke the first choice is intravenous thrombolytic therapy, but does a treatment window of 0-3 hours deliver outcomes significantly better than one of 3-4.5 hours? Arterial hypertension is the single most important modifiable risk factor for ischemic stroke, but what are the effects of blood pressure reduction among acute stroke patients? How effective is blood pressure lowering in primary intracerebral hemorrhage? What are the arguments in favour of continuation versus temporary discontinuation of antihypertensive therapy immediately after acute ischemic stroke? Endovascular procedures (carotid angioplasty/stenting) are increasingly important but what do the data tell us about their safety? Or durability? How do they compare with carotid endarterectomy? The management of unruptured intracranial aneurysms is rife with controversies; clip, coil, wait and watch? The authors examine the evidence for and against.Other sections examine the impact of various risk factors, and special populations. A section on stroke after cardiovascular surgeries reviews the incidence and management of stroke following a whole range of procedures. Another examines special risks during pregnancy.Lastly, the book reviews our understanding of childhood stroke and presents current best practice recommendations for this most challenging group of patients. Over five million people die from stroke each year. We now know that speed of intervention is critical and patient outcomes are determined by a very narrow therapeutic window, during which physicians need to be able to make their choice of treatment rapidly, based on the best evidence available. This book intends to review that evidence. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…

  • Lingua: Inglese

    Editore: TFM Publishing Ltd, GB, 2011

    1903378761 / 9781903378762

    • Rilegato

    Da: Rarewaves USA United, HEBRON, KY, U.S.A.Rarewaves USA United

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 92,23

    EUR 45,48 spedizione 
    Spedito in U.S.A.

    Quantità: 11 disponibili

    Hardback. Condizione: New. Over five million people die from stroke each year. Stroke is also the leading cause of adult disability, affecting over 20 million people world-wide, with two-thirds of stroke victims left permanently disabled. We now know that speed of intervention is critical and patient outcomes are determined by a very narrow therapeutic window, during which physicians need to be able to make their choice of treatment rapidly, based on the best evidence available. The purpose of this book is to review that evidence, for both medical and surgical therapies as well as preventative strategies, drawing on the expertise of leading international authorities to distinguish the issues for which there is a consensus on best practice from those for which the evidence remains inconclusive. For example, for patients with acute ischemic stroke the first choice is intravenous thrombolytic therapy, but does a treatment window of 0-3 hours deliver outcomes significantly better than one of 3-4.5 hours? Arterial hypertension is the single most important modifiable risk factor for ischemic stroke, but what are the effects of blood pressure reduction among acute stroke patients? How effective is blood pressure lowering in primary intracerebral hemorrhage? What are the arguments in favour of continuation versus temporary discontinuation of anti-hypertensive therapy immediately after acute ischemic stroke? Endovascular procedures (carotid angioplasty/stenting) are increasingly important but what do the data tell us about their safety? Or durability? How do they compare with carotid endarterectomy? The management of unruptured intracranial aneurysms is rife with controversies; clip, coil, wait and watch? The authors examine the evidence for and against. Other sections examine the impact of various risk factors, and special populations. A section on stroke after cardiovascular surgeries reviews the incidence and management of stroke following a whole range of procedures including coronary artery bypass grafting, valve replacement surgery, congenital heart disease treatment, aortic surgery, cardiac transplantation and post-carotid endarterectomy. Another examines special risks during pregnancy. Lastly, the book reviews our understanding of childhood stroke -- perinatal, infants and older children, adolescents and young adults - and presents current best practice recommendations for this most challenging group of patients.…

  • Lingua: Inglese

    Editore: TFM Publishing Ltd, GB, 2011

    1903378761 / 9781903378762

    • Rilegato

    Da: Rarewaves.com UK, London, Regno UnitoRarewaves.com UK

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 60,77

    EUR 78,08 spedizione 
    Spedito da Regno Unito a U.S.A.

    Quantità: 2 disponibili

    Hardback. Condizione: New. Over five million people die from stroke each year. Stroke is also the leading cause of adult disability, affecting over 20 million people world-wide, with two-thirds of stroke victims left permanently disabled. We now know that speed of intervention is critical and patient outcomes are determined by a very narrow therapeutic window, during which physicians need to be able to make their choice of treatment rapidly, based on the best evidence available. The purpose of this book is to review that evidence, for both medical and surgical therapies as well as preventative strategies, drawing on the expertise of leading international authorities to distinguish the issues for which there is a consensus on best practice from those for which the evidence remains inconclusive. For example, for patients with acute ischemic stroke the first choice is intravenous thrombolytic therapy, but does a treatment window of 0-3 hours deliver outcomes significantly better than one of 3-4.5 hours? Arterial hypertension is the single most important modifiable risk factor for ischemic stroke, but what are the effects of blood pressure reduction among acute stroke patients? How effective is blood pressure lowering in primary intracerebral hemorrhage? What are the arguments in favour of continuation versus temporary discontinuation of anti-hypertensive therapy immediately after acute ischemic stroke? Endovascular procedures (carotid angioplasty/stenting) are increasingly important but what do the data tell us about their safety? Or durability? How do they compare with carotid endarterectomy? The management of unruptured intracranial aneurysms is rife with controversies; clip, coil, wait and watch? The authors examine the evidence for and against. Other sections examine the impact of various risk factors, and special populations. A section on stroke after cardiovascular surgeries reviews the incidence and management of stroke following a whole range of procedures including coronary artery bypass grafting, valve replacement surgery, congenital heart disease treatment, aortic surgery, cardiac transplantation and post-carotid endarterectomy. Another examines special risks during pregnancy. Lastly, the book reviews our understanding of childhood stroke -- perinatal, infants and older children, adolescents and young adults - and presents current best practice recommendations for this most challenging group of patients.…

  • Lingua: Inglese

    Editore: Tfm Pub Ltd, 2011

    1903378761 / 9781903378762

    • Rilegato

    Da: Mispah books, Redhill, SURRE, Regno UnitoMispah books

    Venditore con 4 stelle
    Contatta il venditore

    Condizione: Usato - Come nuovo

    EUR 148,47

    EUR 30,03 spedizione 
    Spedito da Regno Unito a U.S.A.

    Quantità: 1 disponibile

    Hardcover. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.